levalbuterol has been researched along with roxindole in 1 studies
| Studies (levalbuterol) | Trials (levalbuterol) | Recent Studies (post-2010) (levalbuterol) | Studies (roxindole) | Trials (roxindole) | Recent Studies (post-2010) (roxindole) |
|---|---|---|---|---|---|
| 24 | 5 | 19 | 39 | 4 | 12 |
| Protein | Taxonomy | levalbuterol (IC50) | roxindole (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.0008 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0008 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
1 other study(ies) available for levalbuterol and roxindole
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |